Sciencast Management LP Trims Holdings in Envision Healthcare Corporation (EVHC)

Sciencast Management LP cut its stake in Envision Healthcare Corporation (NYSE:EVHC) by 76.7% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,600 shares of the company’s stock after selling 11,835 shares during the period. Sciencast Management LP’s holdings in Envision Healthcare Corporation were worth $226,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of EVHC. BlackRock Inc. boosted its holdings in Envision Healthcare Corporation by 3,895.0% in the 1st quarter. BlackRock Inc. now owns 7,197,631 shares of the company’s stock valued at $441,359,000 after purchasing an additional 7,017,467 shares during the period. Janus Henderson Group PLC boosted its holdings in Envision Healthcare Corporation by 36,086.8% in the 2nd quarter. Janus Henderson Group PLC now owns 3,945,087 shares of the company’s stock valued at $247,239,000 after purchasing an additional 3,934,185 shares during the period. Maverick Capital Ltd. boosted its holdings in Envision Healthcare Corporation by 66.2% in the 2nd quarter. Maverick Capital Ltd. now owns 5,093,292 shares of the company’s stock valued at $319,197,000 after purchasing an additional 2,028,026 shares during the period. Janus Capital Management LLC boosted its holdings in Envision Healthcare Corporation by 63.7% in the 1st quarter. Janus Capital Management LLC now owns 2,712,066 shares of the company’s stock valued at $167,536,000 after purchasing an additional 1,055,014 shares during the period. Finally, Westfield Capital Management Co. LP bought a new stake in Envision Healthcare Corporation in the 2nd quarter valued at $45,892,000.

A number of equities analysts have recently issued reports on EVHC shares. Cantor Fitzgerald restated a “buy” rating and issued a $80.00 price objective on shares of Envision Healthcare Corporation in a research note on Tuesday, July 4th. Zacks Investment Research upgraded shares of Envision Healthcare Corporation from a “strong sell” rating to a “buy” rating and set a $70.00 price objective for the company in a research note on Tuesday, July 4th. Jefferies Group LLC set a $71.00 price objective on shares of Envision Healthcare Corporation and gave the company a “buy” rating in a research note on Thursday, August 24th. BidaskClub cut shares of Envision Healthcare Corporation from a “hold” rating to a “sell” rating in a research note on Tuesday, August 1st. Finally, Royal Bank Of Canada increased their price objective on shares of Envision Healthcare Corporation from $72.00 to $77.00 and gave the company an “outperform” rating in a research note on Tuesday, June 27th. One analyst has rated the stock with a sell rating, two have issued a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the stock. The company currently has an average rating of “Buy” and a consensus price target of $75.33.

Shares of Envision Healthcare Corporation (EVHC) opened at 42.49 on Wednesday. The company’s 50 day moving average is $47.48 and its 200-day moving average is $55.16. Envision Healthcare Corporation has a 12 month low of $42.13 and a 12 month high of $74.75. The firm’s market cap is $4.97 billion.

Envision Healthcare Corporation (NYSE:EVHC) last posted its quarterly earnings data on Monday, August 7th. The company reported $0.79 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.75 by $0.04. Envision Healthcare Corporation had a negative net margin of 7.35% and a positive return on equity of 5.35%. The business had revenue of $1.95 billion during the quarter, compared to analysts’ expectations of $1.96 billion. During the same quarter in the prior year, the business posted $0.34 earnings per share. Envision Healthcare Corporation’s revenue was up 156.7% compared to the same quarter last year. Equities research analysts predict that Envision Healthcare Corporation will post $1.40 EPS for the current year.

Envision Healthcare Corporation announced that its board has authorized a stock buyback program on Monday, September 18th that permits the company to buyback $250.00 million in shares. This buyback authorization permits the company to buy up to 4.5% of its shares through open market purchases. Shares buyback programs are usually a sign that the company’s leadership believes its stock is undervalued.

TRADEMARK VIOLATION NOTICE: “Sciencast Management LP Trims Holdings in Envision Healthcare Corporation (EVHC)” was first posted by Sports Perspectives and is owned by of Sports Perspectives. If you are reading this report on another site, it was stolen and reposted in violation of US & international copyright law. The legal version of this report can be accessed at https://sportsperspectives.com/2017/10/11/sciencast-management-lp-trims-holdings-in-envision-healthcare-corporation-evhc.html.

Envision Healthcare Corporation Company Profile

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.

Institutional Ownership by Quarter for Envision Healthcare Corporation (NYSE:EVHC)

Receive News & Ratings for Envision Healthcare Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply